Our Science

Mechanism of Action

Existing treatments for gout and hyperuricemia are not always effective in lowering the uric acid to target level to control gout or prevent uric acid from accumulating in the body; these drugs also are often associated with a series of adverse effects that can, in some cases be fatal.

Shanton Pharma’s lead program SAP-001 works through a unique combination of pathways to regulate over production and increase excretion of uric acid to effectively reduce serum uric acid levels.

Read More